Cargando…
Structure–Activity Studies Reveal the Oxazinone Ring Is a Determinant of Cytochrome P450 2B6 Activity Toward Efavirenz
[Image: see text] Cytochrome P450 2B6 (CYP2B6) is primarily responsible for the metabolism of the anti-HIV drug efavirenz (EFV). We set out to explore the molecular basis for CYP2B6 activity toward EFV by examining the metabolism of eight EFV analogues. cDNA-expressed CYP2B6 formed monooxygenated me...
Autores principales: | Cox, Philip M., Bumpus, Namandjé N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191608/ https://www.ncbi.nlm.nih.gov/pubmed/25309681 http://dx.doi.org/10.1021/ml500297n |
Ejemplares similares
-
Biotransformation of Efavirenz and Proteomic Analysis of Cytochrome P450s and UDP-Glucuronosyltransferases in Mouse, Macaque, and Human Brain-Derived In Vitro Systems
por: Wheeler, Abigail M., et al.
Publicado: (2023) -
Inter-ethnic differences in efavirenz CNS toxicity – role of cytochrome P450 2B6 polymorphisms
por: Lee, Lawrence S, et al.
Publicado: (2012) -
In Vitro Activation of Cytochrome
P450 46A1 (CYP46A1) by Efavirenz-Related Compounds
por: Mast, Natalia, et al.
Publicado: (2019) -
Spatial Distribution Profiles of Emtricitabine, Tenofovir,
Efavirenz, and Rilpivirine in Murine Tissues Following In
Vivo Dosing Correlate with Their Safety Profiles in Humans
por: Seneviratne, Herana Kamal, et al.
Publicado: (2020) -
Polymorphisms in Cytochrome P450 are associated with Extensive Efavirenz Pharmacokinetics and CNS Toxicities in an HIV Cohort in Botswana
por: Vujkovic, Marijana, et al.
Publicado: (2018)